You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 132 No. 8, August 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (49)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Comparative Percutaneous Absorption of Lindane and Permethrin

Thomas J. Franz, MD; Paul A. Lehman, MS; Susan F. Franz; Jere D. Guin, MD

Arch Dermatol. 1996;132(8):901-905.


Abstract

Background and Design
Because of the concern for potential neurotoxic effects (central nervous system excitation, convulsions) in the treatment of scabies using 1% lindane lotion, 5% permethrin cream has been suggested as an alternative scabicide. Using the finite dose technique, in vitro percutaneous absorption of 5% permethrin cream or 1% lindane lotion was measured in human and guinea pig skin following a single application. In vivo blood and brain levels of the scabicides were measured in guinea pigs following three daily applications of 5% permethrin cream or 1% lindane lotion. Permethrin and lindane levels were quantified by gas chromatography/mass spectroscopy.

Results
In vitro percutaneous absorption of the two scabicides was identical in guinea pig skin; however, human skin was 20-fold more permeable to lindane than to permethrin. In vivo guinea pig blood and brain levels of lindane were fourfold greater than permethrin levels.

Conclusion
The risk for toxic effects, as assessed by systemic exposure during overuse conditions, is projected to be 40 to 400 times lower for 5% permethrin cream than for 1% lindane lotion.

Arch Dermatol. 1996;132:901-905



Author Affiliations

From the Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pyridostigmine, Diethyltoluamide, Permethrin, and Stress: A Double-Blind, Randomized, Placebo-Controlled Trial to Assess Safety
Roy et al.
Mayo Clin Proc. 2006;81:1303-1310.
ABSTRACT | FULL TEXT  

Clinical practices. Scabies.
Chosidow
NEJM 2006;354:1718-1727.
FULL TEXT  

Organophosphorus Insecticides Induce Airway Hyperreactivity by Decreasing Neuronal M2 Muscarinic Receptor Function Independent of Acetylcholinesterase Inhibition
Lein and Fryer
Toxicol Sci 2005;83:166-176.
ABSTRACT | FULL TEXT  

Skin
Mancini
Pediatrics 2004;113:1114-1119.
ABSTRACT | FULL TEXT  

Comparative Efficacy of Treatments for Pediculosis Capitis Infestations: Update 2000
Meinking et al.
Arch Dermatol 2001;137:287-292.
ABSTRACT | FULL TEXT  

Topical Permethrin Exposure Causes Thymic Atrophy and Persistent Inhibition of the Contact Hypersensitivity Response in C57BI/6 Mice
Punareewattana et al.
International Journal of Toxicology 2000;19:383-389.
ABSTRACT  

Comparing Topical Scabietic Treatments Will Soon Become Extinct
Burkhart et al.
Arch Dermatol 1997;133:1314-1314.
ABSTRACT  

Comparing Antiscabies Treatments
Downs
Arch Dermatol 1997;133:526-526.
ABSTRACT  

Toxicity of Permethrin Cream vs. Lindane Lotion
Journal Watch Dermatology 1996;1996:2-2.
FULL TEXT  

TOXICITY OF PERMETHRIN VS. LINDANE
JWatch General 1996;1996:3-3.
FULL TEXT  

Safety of Permethrin vs Lindane for the Treatment of Scabies
Meinking
Arch Dermatol 1996;132:959-962.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.